- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BEACON Pharmaceutical Ltd (BEAC)
BEACON Pharmaceutical Ltd stock price live, this page displays DH BEAC stock exchange data. View the BEAC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BEACON Pharmaceutical Ltd real time stock price chart below.
What Is the BEACON Pharmaceutical Ltd Stock Price Today?
The BEACON Pharmaceutical Ltd stock price today is 111.20.
What Is the Stock Symbol for BEACON Pharmaceutical Ltd?
The stock symbol for BEACON Pharmaceutical Ltd is "BEAC."
What Stock Exchange Does BEACON Pharmaceutical Ltd Trade On?
BEACON Pharmaceutical Ltd is listed and trades on the DSE stock exchange.
Is BEACON Pharmaceutical Ltd a Good Stock to Buy?
Determining whether BEACON Pharmaceutical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BEAC quote. (ISIN: BD0482BECON5)
What Is the BEACON Pharmaceutical Ltd Stock Price Today?
The BEACON Pharmaceutical Ltd stock price today is 111.20.
What Is the Stock Symbol for BEACON Pharmaceutical Ltd?
The stock symbol for BEACON Pharmaceutical Ltd is "BEAC."
What Stock Exchange Does BEACON Pharmaceutical Ltd Trade On?
BEACON Pharmaceutical Ltd is listed and trades on the DSE stock exchange.
Is BEACON Pharmaceutical Ltd a Good Stock to Buy?
Determining whether BEACON Pharmaceutical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BEAC quote. (ISIN: BD0482BECON5)
DSE
Currency in BDT
111.20
+6.60(+6.31%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
105.10
112.60
52 wk Range
92.40
169.00
BEAC Scorecard
Full Analysis
Significant return over the last week
BEAC is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
105.10112.60
52 wk Range
92.40169.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.80%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.80%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BEAC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
No news in this category
Looks like there are no results in this news category
BEACON Pharma Company Profile
Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestinal, infectious diseases, immunology, rheumatology, pediatrics, and nutritional supplements, etc. In addition, the company offers contract and toll manufacturing services. The company provides its products under the Pemro, Nivomab, Xelpac Premium, Docexan, Xaloplat Aqua, Gemoxen Aqua, ETP, FXR, Renesis, Mezest, Eposis, Tirza, Xelmet, Xerova, Sinjard, Ovocal, Haxinor, Tetrazin, Lubilux, Paloxi, Olonex, and Bukof brand name. Beacon Pharmaceuticals PLC was incorporated in 2001 and is based in Dhaka, Bangladesh.
Compare BEAC to Peers and Sector
Metrics to compare | BEAC | Peers Peers - average of corresponding metrics from companies closely matching BEAC: IBP, SILVAPHL, CENTRALPHL, SQURPHARMA, ORIONPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBEACPeersSector |
|---|---|---|---|---|
P/E Ratio | 45.1x | 8.8x | −0.4x | |
PEG Ratio | −3.24 | −0.54 | 0.00 | |
Price/Book | 3.9x | 0.8x | 2.6x | |
Price / LTM Sales | 2.2x | 2.4x | 2.9x | |
Upside (Analyst Target) | - | 45.2% | 54.4% | |
Fair Value Upside | Unlock | 15.3% | 9.3% | Unlock |
Earnings
Latest Release
Feb 03, 2025
EPS / Forecast
1.91 / --
Revenue / Forecast
3.18B / --
FAQ
What Is the BEACON Pharma (BEAC) Stock Price Today?
The BEACON Pharma stock price today is 111.20.
What Stock Exchange Does BEACON Pharma Trade On?
BEACON Pharma is listed and trades on the Dhaka Stock Exchange stock exchange.
What Is the Stock Symbol for BEACON Pharma?
The stock symbol for BEACON Pharma is "BEAC."
Does BEACON Pharma Pay Dividends? What’s The Current Dividend Yield?
The BEACON Pharma dividend yield is 1.8%.
What Is the BEACON Pharma Market Cap?
As of today, BEACON Pharma market cap is 25.69B.
What Is BEACON Pharma's Earnings Per Share (TTM)?
The BEACON Pharma EPS (TTM) is 2.47.
From a Technical Analysis Perspective, Is BEAC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has BEACON Pharma Stock Split?
BEACON Pharma has split 1 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.